A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide (Q64074407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

title

A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Elijah F Edmondson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

author name string

Kevin R Trabbic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Kaitlyn Whalen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Karin Abarca-Heideman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Li Xia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Jeffrey C Gildersleeve

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

Joseph J Barchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

language of work or name

English

0 references

publication date

5 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

page(s)

5662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

describes a project that uses

2 May 2020

ImageQuant

object named as

ImageQuant

2 references

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6450958/fullTextXML

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Novel pancreatic cancer vaccines could unleash the army within

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Algenpantucel-L immunotherapy in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Mucins in cancer: protection and control of the cell surface

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Mucins in cancer: function, prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Tumour-associated carbohydrate antigens in breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

The development of synthetic antitumour vaccines from mucin glycopeptide antigens

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Recent Advances In Developing Synthetic Carbohydrate-Based Vaccines For Cancer Immunotherapies

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Jaa-f11: extending the life of mice with breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Cancer vaccines and carbohydrate epitopes

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Design of a MUC1-based cancer vaccine

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

https://api.crossref.org/works/10.1038/S41598-019-42076-2

1 reference

7 January 2021

MUC1 is a promising therapeutic target for prostate cancer therapy

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

MUC1 as a target antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

MUC1, the renaissance molecule

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Design and Synthesis of Multifunctional Gold Nanoparticles Bearing Tumor-Associated Glycopeptide Antigens as Potential Cancer Vaccines

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Glycan microarrays: powerful tools for biomarker discovery

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Multidimensional glycan arrays for enhanced antibody profiling

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Overlooked benefits of using polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Construction and use of glycan microarrays

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

The Glycan Array Platform as a Tool to Identify Carbohydrate Antigens

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

General Procedure for the Synthesis of Neoglycoproteins and Immobilization on Epoxide-Modified Glass Slides

1 reference

https://api.crossref.org/works/10.1038/S41598-019-42076-2

7 January 2021

Mucin gene expression in colonic tissues and cell lines.

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

1 reference

12 December 2020

Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix

1 reference

12 December 2020

Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.

1 reference

12 December 2020

Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials

1 reference

12 December 2020

Mucin expression profile of benign and malignant cervical tissues and correlation with clinical-pathologic parameters

1 reference

12 December 2020

10.1038/S41598-019-42076-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30952968 AND SRC:MED&resulttype=core&format=json

2 May 2020

PubMed publication ID

30952968

1 reference